Journey Medical Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Journey Medical Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q3 2024.
  • Journey Medical Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.39M, a 114% decline year-over-year.
  • Journey Medical Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$18.3M, a 48.4% decline year-over-year.
  • Journey Medical Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$3.85M, a 87% increase from 2022.
  • Journey Medical Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$29.6M, a 32.7% increase from 2021.
  • Journey Medical Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$44M, a 933% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$18.3M -$2.39M -$19.2M -114% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $843K -$3.36M +$5M +59.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$4.16M -$10.4M -$306K -3.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$3.85M -$2.14M +$8.5M +79.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$12.4M $16.8M +$26.9M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$39.2M -$8.36M -$835K -11.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$38.4M -$10.1M -$8.76M -636% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$29.6M -$10.6M +$11.1M +51.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$40.7M -$10.1M +$566K +5.32% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$41.3M -$7.53M +$4.34M +36.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$45.6M -$1.38M -$1.65M -614% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$44M -$21.8M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$10.6M -$10.7M -36810% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$11.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $268K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $29K Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.